ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

Eye Institute Director Kupfer Steps Down; UICC Begins Web-Based Surgical Pathology.

July 7, 2000

Final Issue of the Year

December 13, 1985

Neuro-Oncologist Schold Leaves Duke For UPCI; Rosner Leads Institute At Chicago.

September 1, 2000

Moses, Wattenberg Lead AACR; NCI Budget Cut By $4.8 Mil. For Shannon Awards Contribution

May 24, 1991

Bypass Budget Is Realistic, Defensible Plan, Broder Says

September 27, 1991

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003